ORASONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Orasone, and when can generic versions of Orasone launch?
Orasone is a drug marketed by Solvay and is included in two NDAs.
The generic ingredient in ORASONE is prednisone. There are sixteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the prednisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Orasone
A generic version of ORASONE was approved as prednisone by WATSON LABS on December 31st, 1969.
Summary for ORASONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 114 |
| Patent Applications: | 4,631 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ORASONE at DailyMed |
Recent Clinical Trials for ORASONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 2 |
| ADC Therapeutics | Phase 2 |
| Joseph Tuscano | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for ORASONE
US Patents and Regulatory Information for ORASONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | ORASONE | prednisone | TABLET;ORAL | 083009-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Solvay | ORASONE | prednisone | TABLET;ORAL | 083009-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Solvay | ORASONE | prednisone | TABLET;ORAL | 083009-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
